BIO NMDCAT

Mercury forms stable bonds with sulfhydryl (-SH) groups in enzymes, causing irreversible inhibition and loss of enzyme activity. Concept tested: Heavy metal inhibition.

Drugs are designed to inhibit specific target enzymes while minimizing effects on normal cellular metabolism. Concept tested: Therapeutic significance of enzyme inhibitors.

Since excess substrate cannot overcome non-competitive inhibition, enzyme activity remains reduced. Competitive inhibition would be reversed by increasing substrate concentration. Concept tested: Differentiating inhibitor types.

Reversible inhibitors bind through weak interactions and can dissociate from the enzyme, restoring activity. Permanent destruction occurs only with irreversible inhibitors. Concept tested: Reversible inhibition.

Non-competitive inhibitors bind at sites other than the active site and can bind regardless of substrate occupancy. Competitive inhibitors require access to the active site. Concept tested: Binding characteristics of inhibitors.

Controlled inhibition ensures that metabolic pathways operate according to cellular requirements, preventing wasteful or harmful overactivity. Concept tested: Homeostatic regulation.

Cyanide is a potent enzyme inhibitor that blocks critical enzymes involved in cellular respiration, leading to severe impairment of ATP production. The other options are incorrect. Concept tested: Medical and biochemical significance of enzyme inhibition.**

Increasing enzyme concentration provides more active sites, allowing more substrate molecules to bind despite the presence of the inhibitor. Concept tested: Effect of enzyme concentration on inhibition.

Reversible inhibitors bind temporarily and can dissociate from the enzyme. Removing them restores enzyme activity. Irreversible inhibitors permanently inactivate the enzyme. Concept tested: Reversible vs. irreversible inhibition.

Many antibiotics selectively inhibit bacterial enzymes required for vital metabolic pathways. They do not work by activating enzymes or universally destroying DNA. Concept tested: Medical application of enzyme inhibitors.

Competitive inhibitors compete directly with the substrate for the active site, reducing substrate binding. They do not affect enzyme synthesis or ATP production. Concept tested: Mechanism of competitive inhibition.

Binding at an allosteric site changes the enzyme's conformation, altering the active site's ability to bind substrate effectively. The other options are incorrect. Concept tested: Allosteric inhibition.

Many enzyme inhibitors regulate metabolic pathways by controlling enzyme activity. The other options do not represent normal biological roles of inhibitors. Concept tested: Physiological importance of inhibitors.

Excess substrate successfully competes with a competitive inhibitor, increasing enzyme activity. This effect is not observed with non-competitive or irreversible inhibitors. Concept tested: Experimental reasoning.

Non-competitive inhibitors decrease the maximum reaction rate because some enzyme molecules become inactive regardless of substrate concentration. The other statements are incorrect. Concept tested: Effect on enzyme kinetics.

Many medicines work by selectively inhibiting enzymes. Examples include drugs that inhibit bacterial enzymes or enzymes involved in cholesterol synthesis. The remaining options are biologically incorrect. Concept tested: Medical application of enzyme inhibitors.

Competitive inhibitors resemble the substrate and compete for the enzyme's active site. Allosteric sites are involved in non-competitive inhibition, while coenzymes and products are not the primary binding sites for competitive inhibitors. Concept tested: Active site specificity.

Non-competitive inhibitors bind at an allosteric site and alter the enzyme's three-dimensional shape, reducing catalytic efficiency. They do not necessarily destroy the substrate or all proteins. Concept tested: Mechanism of non-competitive inhibition.

Heavy metals such as lead commonly inhibit enzymes by binding strongly to functional groups, causing irreversible loss of activity. They neither serve as coenzymes nor enhance enzyme synthesis. Concept tested: Heavy metal inhibition.